Reply to: Oligoclonality of TRBC1 and TRBC2 in T cell lymphomas as mechanism of primary resistance to TRBC-directed CAR T cell therapies

Podobne knjige/članki

• Reply to: Oligoclonality of TRBC1 and TRBC2 in T cell lymphomas as mechanism of primary resistance to TRBC-directed CAR T cell therapies
  od: Mathieu Ferrari, et al.
  Izdano: (2025-01-01)
• TRBC1/TRBC2 Immunophenotyping Provides Added Value During the Diagnostic Workup of T‐Cell Lymphoma
  od: Joseph Taylor, et al.
  Izdano: (2025-12-01)
• Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies
  od: Mathieu Ferrari, et al.
  Izdano: (2024-02-01)
• P026 | IDENTIFICATION OF PATHOLOGICAL T-CELL POPULATIONS IN T-CELL LYMPHOMAS USING TRBC1/TRBC2 FLOW CYTOMETRY ANALYSIS
  od: S. Bellesi, et al.
  Izdano: (2025-09-01)
• Evaluation of Molecular Simulations and Deep Learning Prediction of Antibodies’ Recognition of TRBC1 and TRBC2
  od: Xincheng Zeng, et al.
  Izdano: (2023-09-01)